Homo naledi, a new species of the genus Homo from the Dinaledi Chamber, South Africa

  1. Lee R Berger
  2. John Hawks
  3. Darryl J de Ruiter
  4. Steven E Churchill
  5. Peter Schmid
  6. Lucas K Delezene
  7. Tracy L Kivell
  8. Heather M Garvin
  9. Scott A Williams
  10. Jeremy M DeSilva
  11. Matthew M Skinner
  12. Charles M Musiba
  13. Noel Cameron
  14. Trenton W Holliday
  15. William Harcourt-Smith
  16. Rebecca R Ackermann
  17. Markus Bastir
  18. Barry Bogin
  19. Debra Bolter
  20. Juliet Brophy
  21. Zachary D Cofran
  22. Kimberly A Congdon
  23. Andrew S Deane
  24. Mana Dembo
  25. Michelle Drapeau
  26. Marina C Elliott
  27. Elen M Feuerriegel
  28. Daniel Garcia-Martinez
  29. David J Green
  30. Alia Gurtov
  31. Joel D Irish
  32. Ashley Kruger
  33. Myra F Laird
  34. Damiano Marchi
  35. Marc R Meyer
  36. Shahed Nalla
  37. Enquye W Negash
  38. Caley M Orr
  39. Davorka Radovcic
  40. Lauren Schroeder
  41. Jill E Scott
  42. Zachary Throckmorton
  43. Caroline VanSickle
  44. Christopher S Walker
  45. Pianpian Wei
  46. Bernhard Zipfel
  1. University of the Witwatersrand, South Africa
  2. University of Wisconsin-Madison, United States
  3. Texas A&M University, United States
  4. Duke University, United States
  5. University of Zurich, Switzerland
  6. University of Arkansas, United States
  7. University of Kent, United Kingdom
  8. Max Planck Institute for Evolutionary Anthropology, Germany
  9. Mercyhurst University, United States
  10. New York University, United States
  11. New York Consortium in Evolutionary Primatology, United States
  12. Dartmouth College, United States
  13. University of Colorado Denver, United States
  14. Loughborough University, United Kingdom
  15. Tulane University, United States
  16. Lehman College, United States
  17. American Museum of Natural History, United States
  18. University of Cape Town, South Africa
  19. Museo Nacional de Ciencias Naturales, Spain
  20. Modesto Junior College, United States
  21. Louisiana State University, United States
  22. Nazarbayev University, Kazakhstan
  23. University of Missouri, United States
  24. University of Kentucky College of Medicine, United States
  25. Simon Fraser University, Canada
  26. Université de Montréal, Canada
  27. Australian National University, Australia
  28. Biology Department, Universidad Autònoma de Madrid, Spain
  29. Midwestern University, United States
  30. Liverpool John Moores University, United Kingdom
  31. University of Pisa, Italy
  32. Chaffey College, United States
  33. University of Johannesburg, South Africa
  34. George Washington University, United States
  35. University of Colorado School of Medicine, United States
  36. Croatian Natural History Museum, Croatia
  37. University of Iowa, United States
  38. Lincoln Memorial University, United States
  39. Smithsonian Institution, United States
  40. Institute of Vertebrate Paleontology and Paleoanthropology, China

Peer review process

Version of Record: This is the final version of the article.

Read more about eLife's peer review process.

Editors

Senior Editor
  1. Kenton J Swartz
  2. National Institute of Neurological Disorders and Stroke, National Institutes of Health, United States
Reviewing Editor
  1. Randy B Stockbridge
  2. University of Michigan, United States

Reviewer #1 (Public Review):

In this study, the authors seek to determine the potential role of aging-induced iron accumulation on the effects of hormone replacement therapy (HRT) on atherosclerosis in late postmenopausal women. The authors are commended for the novel and relevant line of investigation and the many complex experiments that they performed. Central to the manuscript, the authors find that high iron levels, in late postmenopausal women as well as in ApoE-/- mice, are associated with reduced expression of the estrogen receptor (ERα). Also, estradiol (E2) treatment in ApoE-/- mice further downregulated ERα expression, but the authors have not sufficiently demonstrated that this occurs in an iron-dependent manner, as the authors have concluded in section 3.3. The data showed that high iron and E2 treatment trigger the ubiquitin proteasome degradation pathway to degrade ERα via Mdm2-mediated degradation. Interestingly, iron chelation therapy restored ERα expression and attenuated E2-triggered atherosclerosis in late postmenopausal mice. Overall, the authors have concluded that in late postmenopause, iron accumulation prevents the HRT benefit through negative regulation of ERα expression via Mdm2-mediated proteolysis. However, important control groups in the in vivo experiments need to be included to support the conclusions made by the authors and variability in the in vitro experiments diminishes enthusiasm for the findings. Furthermore, in the in vitro experiments, the predominant reduction in ERalpha expression appears to be driven by iron even in the absence of E2, thus making it uncertain how specific these findings are to menopause.

Reviewer #2 (Public Review):

It is believed that the reason why women generally have lower rates of atherosclerotic events than men until menopause is due to the beneficial effects of estrogen on the cardiovascular system. The paper attempts to explain why hormone replacement therapy with estrogen is not effective in preventing atherosclerosis in post-menopausal women. The authors posit that accumulation of iron after menopause inhibits estrogen receptor expression and makes estrogen ineffective. Using mouse model of atherosclerosis and iron overload, they demonstrate that 1)atherosclerosis is increased in overectomized mice 2) estrogen supplement seems to further exacerbate atherosclerosis and this is accompanied by increased total body iron; 3) iron itself causes a decrease in ERa via increased proteasome degradation of Era via E3 ligase MDM2 and 4) iron chelation rescues the protective effects of estrogen in overectomized mice on atherosclerosis progression.

While interesting in terms of hypothesis, I found the manuscript (not the overall themes) but the individual experimental logic difficult to follow with unclear rationale for many of the experiments and timepoints chosen. Moreover the human data supporting these claims are weak in terms of what is shown. The authors only partially achieve their aims as many of the experiments in mice appear incomplete in terms of data shown and transparency. Some important controls are also missing.

This work has important potential to understand the causes of accelerated atherosclerosis in women after menopause and how to better prevent atherosclerosis in women of this age group

Reviewer #3 (Public Review):

This manuscript aims to address whether age-related iron status influences differential effects of estrogen replacement on atherogenesis in postmenopausal females. Specifically, whether age-related iron accumulation reduces estrogen signaling through ERa receptor in relevant cell types (endothelial cells and macrophages). They test this fairly rigorously using in vitro, preclinical and clinical data, and the data is presented logically.

First, the authors demonstrate that in postmenopausal women, there is an inverse correlation between age-related increase in iron levels and age-related decrease in ERa levels in atherosclerotic plaques. This is consistent with the fact that, in ovariectomized (OVX) pro-atherogenic (ApoE KO) mice, there is differential effect of estrogen (E2) on ERa, atherosclerosis, lipid profiles and key biomarkers (ABCA1, eNOS, etc) based on age (early: 16 weeks, versus late: 40 weeks), with young mice responding favorably while older mice responding negatively. Consistent with this, in the older OVX ApoE KO mice, E2 treatment worsened atherosclerosis. Importantly, they point this differential effect of E2 to iron overload in macrophages using ApoE KO; LysM-macrophage-specific Fpn1 KO as E2 now has deleterious effects regardless of age. Next, using ferric ammonium citrate (FAC) to supplement iron and deferiprone (DFP) to chelate iron, they show that iron manipulation impacts the E2 response appropriately in the relevant cell types (endothelial cells and macrophage cells). Then they provide evidence for the MdM2-mediated post-translational regulation of ERa as a mechanism by which iron status impacts differential E2 has differential effects on ERa. Finally, they test the impact of systemic iron chelation on the OVX ApoE KO mice model of atherosclerosis and show that iron chelation attenuates the deleterious effects of E2 in late postmenopausal mice.

Overall the evidence is solid and logically laid out. Given that serum iron levels do not correlate with the rest of the story, inclusion of LysM-macrophage-specific Fpn1 KO provides the key evidence that iron loading in macrophages drives differential effects to E2 in postmenopausal mice. The paper provides evidence that iron levels influence how the relevant cells respond to E2 with clinical implications to hormonal replacement therapy in younger and older postmenopausal women. While this study is limited by a small clinical sample size, it provides an important framework for future studies on the impact of age-related iron status on the response to hormonal replacement therapy.

Article download links

A list of links to download the article, or parts of the article, in various formats.

Download formats (links to download the article or parts of the article as PDF, and in DAR format)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Lee R Berger
  2. John Hawks
  3. Darryl J de Ruiter
  4. Steven E Churchill
  5. Peter Schmid
  6. Lucas K Delezene
  7. Tracy L Kivell
  8. Heather M Garvin
  9. Scott A Williams
  10. Jeremy M DeSilva
  11. Matthew M Skinner
  12. Charles M Musiba
  13. Noel Cameron
  14. Trenton W Holliday
  15. William Harcourt-Smith
  16. Rebecca R Ackermann
  17. Markus Bastir
  18. Barry Bogin
  19. Debra Bolter
  20. Juliet Brophy
  21. Zachary D Cofran
  22. Kimberly A Congdon
  23. Andrew S Deane
  24. Mana Dembo
  25. Michelle Drapeau
  26. Marina C Elliott
  27. Elen M Feuerriegel
  28. Daniel Garcia-Martinez
  29. David J Green
  30. Alia Gurtov
  31. Joel D Irish
  32. Ashley Kruger
  33. Myra F Laird
  34. Damiano Marchi
  35. Marc R Meyer
  36. Shahed Nalla
  37. Enquye W Negash
  38. Caley M Orr
  39. Davorka Radovcic
  40. Lauren Schroeder
  41. Jill E Scott
  42. Zachary Throckmorton
  43. Matthew W Tocheri
  44. Caroline VanSickle
  45. Christopher S Walker
  46. Pianpian Wei
  47. Bernhard Zipfel
(2015)
Homo naledi, a new species of the genus Homo from the Dinaledi Chamber, South Africa
eLife 4:e09560.
https://doi.org/10.7554/eLife.09560

Share this article

https://doi.org/10.7554/eLife.09560